Masco Corporation · MAS · FY2026 Q2 · Calendar Q3 2026
Masco raises EPS outlook as tariff refund boosts Q2 profit
Masco's Q2 showed strong profit growth and a higher EPS outlook, but the evidence is mixed: the quarter benefited materially from a tariff refund while sales declined. The longer-term case depends on plumbing investments, new products, wellness growth and sustained cost control translating into organic demand and margin gains.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about MAS FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The earnings analysis shows a higher 2026 EPS outlook, a $95 million Q2 net IEEPA tariff refund, completion of the Bristan divestiture and an increase in planned 2026 share-repurchase or acquisition spending to approximately $1 billion.
Guidance delta
Management raised 2026 EPS guidance to $4.40-$4.60 from $4.10-$4.30 previously, with the increase reflecting a one-time tariff benefit and underlying execution.
Key takeaways
- Operating profit rose 17% and EPS increased 26%, supported by a $95 million net IEEPA tariff refund, pricing and cost savings.
- Net sales declined 3% year over year; management said underlying sales were flat excluding strategic investment impacts.
- Masco plans about $1 billion of 2026 capital allocation for share repurchases or acquisitions while investing in plumbing growth.
Management priorities
- Launch five new kitchen and bath collections across Delta, Brizo and Newport Brass.
- Invest in plumbing channels, wellness and premium water experiences to support long-term growth.
- Pursue operating-margin expansion toward approximately 18% for Masco and 20% for plumbing in 2026.
Follow MAS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Sep 11, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 31, 2026 |
| UBS | Buy | Buy | Maintain | Jul 30, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 30, 2026 |
| Evercore ISI Group | In Line | Outperform | Downgrade | Jul 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 24, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Apr 23, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 23, 2026 |
| Baird | Neutral | Neutral | Maintain | Apr 23, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Apr 20, 2026 |
| Argus Research | Buy | Buy | Maintain | Nov 5, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 4, 2025 |
| Loop Capital | Hold | Hold | Maintain | Aug 4, 2025 |
| Jefferies | Hold | Hold | Maintain | Apr 23, 2025 |
| Deutsche Bank | Hold | Sell | Upgrade | Feb 13, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Feb 10, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Feb 10, 2023 |
| Wolfe Research | Perform | Peer Perform | Maintain | Mar 17, 2021 |
| Raymond James | Market Perform | Strong Buy | Downgrade | May 29, 2020 |
| Nomura Instinet | Buy | Buy | Maintain | Apr 30, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 30, 2020 |
| Atlantic Equities | Overweight | Overweight | Maintain | Dec 16, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Sep 19, 2019 |
| Buckingham Research | Neutral | Buy | Downgrade | Sep 18, 2019 |
| Buckingham | Neutral | Buy | Downgrade | Sep 18, 2019 |
| Bank of America | Buy | Buy | Maintain | Sep 18, 2019 |
| Longbow Research | Neutral | Buy | Downgrade | Oct 12, 2018 |
| B. Riley Securities | Buy | Buy | Maintain | Aug 1, 2018 |
| B. Riley FBR | Buy | Buy | Maintain | Aug 1, 2018 |
| Gabelli & Co. | Buy | Hold | Upgrade | Apr 25, 2018 |
| Argus | Buy | Buy | Maintain | Oct 26, 2017 |
| FBR Capital | Buy | Buy | Maintain | Oct 25, 2017 |
| MKM Partners | Buy | Neutral | Upgrade | Oct 26, 2016 |
| Vertical Research | Hold | Buy | Downgrade | Mar 31, 2016 |
| Macquarie | Outperform | Neutral | Upgrade | Jan 6, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $68.16. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $80 | $73.19 | +17.4% | Aug 24, 2026 |
| Deutsche Bank | Analyst unavailable | $74 | $73.26 | +8.6% | Aug 3, 2026 |
| UBS | Analyst unavailable | $94 | $71.29 | +37.9% | Jul 30, 2026 |
| Wells Fargo | Sam Reid | $87 | $76.2 | +27.6% | Jul 14, 2026 |
| Barclays | Analyst unavailable | $82 | $76.2 | +20.3% | Jul 14, 2026 |
| UBS | John Lovallo | $97 | $75.3 | +42.3% | Apr 23, 2026 |
| RBC Capital | Analyst unavailable | $72 | $74.87 | +5.6% | Apr 23, 2026 |
| Robert W. Baird | Analyst unavailable | $80 | $73.96 | +17.4% | Apr 23, 2026 |
| Goldman Sachs | Analyst unavailable | $90 | $73.96 | +32.0% | Apr 23, 2026 |
| Barclays | Matthew Bouley | $78 | $73.96 | +14.4% | Apr 22, 2026 |
| Truist Financial | Keith Hughes | $90 | $73.96 | +32.0% | Apr 22, 2026 |
| Robert W. Baird | Analyst unavailable | $72 | $66.68 | +5.6% | Apr 21, 2026 |
| BMO Capital | Analyst unavailable | $75 | $66.04 | +10.0% | Apr 20, 2026 |
| BMO Capital | Analyst unavailable | $77 | $77.26 | +13.0% | Feb 12, 2026 |
| Oppenheimer | Tyler Batory | $88 | $76.14 | +29.1% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $78 | $76.64 | +14.4% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $82 | $77.82 | +20.3% | Feb 11, 2026 |
| Wells Fargo | Sam Reid | $78 | $69.85 | +14.4% | Jan 14, 2026 |
| RBC Capital | Mike Dahl | $67 | $67.22 | -1.7% | Jan 9, 2026 |
| Wells Fargo | Sam Reid | $75 | $63.92 | +10.0% | Dec 15, 2025 |
| Argus Research | Chris Graja | $80 | $61.66 | +17.4% | Nov 5, 2025 |
| UBS | Analyst unavailable | $84 | $66.01 | +23.2% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $76 | $65.22 | +11.5% | Oct 30, 2025 |
| Loop Capital Markets | Analyst unavailable | $73 | $69.46 | +7.1% | Aug 4, 2025 |
| Oppenheimer | Analyst unavailable | $79 | $69.46 | +15.9% | Aug 4, 2025 |
| Loop Capital Markets | Garik Shmois | $62 | $59.92 | -9.0% | Apr 24, 2025 |
| UBS | John Lovallo | $80 | $59.86 | +17.4% | Apr 24, 2025 |
| Barclays | Matthew Bouley | $71 | $59.32 | +4.2% | Apr 24, 2025 |
| Truist Financial | Keith Hughes | $75 | $59.32 | +10.0% | Apr 23, 2025 |
| Wells Fargo | Sam Reid | $82 | $77.29 | +20.3% | Feb 4, 2025 |
| RBC Capital | Mike Dahl | $74 | $72.13 | +8.6% | Jan 10, 2025 |
| Loop Capital Markets | Garik Shmois | $81 | $71.7 | +18.8% | Jan 8, 2025 |
| Wells Fargo | Sam Reid | $85 | $79.35 | +24.7% | Dec 17, 2024 |
| Jefferies | Philip Ng | $89 | $79.35 | +30.6% | Dec 16, 2024 |
| Loop Capital Markets | Garik Shmois | $87 | $80.63 | +27.6% | Oct 30, 2024 |
| Truist Financial | Keith Hughes | $92 | $81.3 | +35.0% | Oct 29, 2024 |
| Wells Fargo | Sam Reid | $92 | $82.37 | +35.0% | Oct 7, 2024 |
| Truist Financial | Keith Hughes | $84 | $78.31 | +23.2% | Sep 3, 2024 |
| Robert W. Baird | Timothy Wojs | $88 | $75.84 | +29.1% | Jul 26, 2024 |
| Robert W. Baird | Timothy Wojs | $84 | $72.73 | +23.2% | Jul 22, 2024 |
| Barclays | Matthew Bouley | $79 | $69.22 | +15.9% | Jul 12, 2024 |
| Loop Capital Markets | Garik Shmois | $76 | $69.74 | +11.5% | Apr 25, 2024 |
| RBC Capital | Mike Dahl | $80 | $69.74 | +17.4% | Apr 25, 2024 |
| BMO Capital | Analyst unavailable | $68 | $52.69 | -0.2% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $68 | $54.32 | -0.2% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $60 | $52.87 | -12.0% | Apr 21, 2022 |
| J.P. Morgan | Analyst unavailable | $54 | $51.89 | -20.8% | Apr 20, 2022 |
| Barclays | Matthew Bouley | $75 | $57.25 | +10.0% | Feb 14, 2022 |
| Truist Financial | Keith Hughes | $80 | $67.97 | +17.4% | Jan 5, 2022 |
| Bank of America Securities | Rafe Jadrosich | $75 | $63.5 | +10.0% | Nov 8, 2021 |
| Wells Fargo | Deepa Raghavan | $70 | $64.93 | +2.7% | Oct 28, 2021 |
| Goldman Sachs | Susan Maklari | $73 | $58.18 | +7.1% | Jun 30, 2021 |
| Argus Research | Chris Graja | $74 | $64.08 | +8.6% | May 3, 2021 |
| BMO Capital | Ketan Mamtora | $67 | $62.84 | -1.7% | Apr 30, 2021 |
Track every rating change on MAS the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMasco Corporation is a prominent global manufacturer and distributor of home improvement and building products, serving markets across North America, Europe, and other international regions. The company operates through two main segments. Its Plumbing Products division offers a vast array of items, from fixtures like faucets, showerheads, and valves to comprehensive bathing solutions such as tubs, shower bases, sinks, and toilets. This segment also provides high-end offerings like spas, exercise pools, and fitness systems, alongside crucial plumbing system components made from brass, copper, and composites, as well as connected water technologies, thermoplastic solutions, and PEX tubing. These products are sold under numerous recognized brands, including DELTA, HANSGROHE, KRAUS, HOT SPRING, and ENDLESS POOLS. The Decorative Architectural Products segment enhances both the aesthetic and functional aspects of homes.…
Historical context
All MAS earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| HMY Harmony Gold Mining Company Limited | FY2026 Q4 · Calendar Q3 2026 | 0.0% | -6.2% | Harmony Gold posts record FY2026 while Eva Copper risks remain |
Latest beats and misses
Who reports nextBeat on EPS
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
Get the MAS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-29T20:08:53.946284+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-09-23T18:30:54.989890+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T18:30:54.987113+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.